{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:33:17Z","timestamp":1792492397354,"version":"4.5.0"},"reference-count":40,"publisher":"National Academy of Sciences","issue":"10","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":181,"URL":"https:\/\/www.pnas.org\/site\/aboutpnas\/licenses.xhtml"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZO1 BC008753"],"award-info":[{"award-number":["ZO1 BC008753"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2019,3,5]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Regulatory T cells (Tregs) protect cancer cells from immune attack. Tregs express CD25 on their surface and can be killed by antibodies and immunoconjugates targeting CD25. These agents have not been effective in controlling tumor growth, probably because they also kill cytotoxic CD8 T cells expressing CD25 that are needed for antitumor activity. To overcome these deficiencies, we have directly injected tumors with a potent anti-CD25 immunotoxin, 2E4-PE38, that kills CD25-expressing Treg cells in the tumor, causes injected and distant tumors to regress, and induces antitumor immunity. Because 2E4-PE38 is present at very low concentrations in the blood, it does not kill CD25-expressing cells at distant sites. This strategy could be employed for treating tumors in people.<\/jats:p>","DOI":"10.1073\/pnas.1820388116","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T19:39:20Z","timestamp":1550086760000},"page":"4575-4582","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":113,"title":["Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity"],"prefix":"10.1073","volume":"116","author":[{"given":"Masanori","family":"Onda","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-0270","authenticated-orcid":false,"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"e_1_3_3_1_2","first-page":"723","article-title":"Cell interactions in the induction of tolerance: The role of thymic lymphocytes","volume":"18","author":"Gershon RK","year":"1970","unstructured":"RK Gershon, K Kondo, Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 18, 723\u2013737 (1970).","journal-title":"Immunology"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1988.tb02344.x"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi S","year":"1995","unstructured":"S Sakaguchi, N Sakaguchi, M Asano, M Itoh, M Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151\u20131164 (1995).","journal-title":"J Immunol"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2250"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.6840"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1"},{"key":"e_1_3_3_8_2","first-page":"1","article-title":"Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice","volume":"2","author":"Jones E","year":"2002","unstructured":"E Jones, , Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun 2, 1 (2002).","journal-title":"Cancer Immun"},{"key":"e_1_3_3_9_2","first-page":"3128","article-title":"Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody","volume":"59","author":"Onizuka S","year":"1999","unstructured":"S Onizuka, , Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59, 3128\u20133133 (1999).","journal-title":"Cancer Res"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep15179"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27745"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130762"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300271"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080099"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.823"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939613"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu J","year":"1999","unstructured":"J Shimizu, S Yamazaki, S Sakaguchi, Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity. J Immunol 163, 5211\u20135218 (1999).","journal-title":"J Immunol"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1439305"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0140-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1757"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003330"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4919"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000187959.45803.0c"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.26"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0866-5"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0013"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130579"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.013"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.001"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0330"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0869"},{"key":"e_1_3_3_33_2","first-page":"5070","article-title":"Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity","volume":"61","author":"Onda M","year":"2001","unstructured":"M Onda, , Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity. Cancer Res 61, 5070\u20135077 (2001).","journal-title":"Cancer Res"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4488"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6843"},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4049\/jimmunol.133.4.1970","article-title":"The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells","volume":"133","author":"Ortega G","year":"1984","unstructured":"G Ortega, RJ Robb, EM Shevach, TR Malek, The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells. J Immunol 133, 1970\u20131975 (1984).","journal-title":"J Immunol"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","unstructured":"M Onda Recombinant immunotoxins with low endotoxins for clinical and animal studies. Antibody Engineering. Methods and Protocols Methods in Molecular Biology ed Chames P (Humana Press Totowa NJ) pp 627\u2013643. (2012).","DOI":"10.1007\/978-1-61779-974-7_35"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804851105"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/1480-9222-14-6"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.12.8822"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1820388116","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1820388116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T12:33:54Z","timestamp":1694608434000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1820388116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,3,5]]}},"alternative-id":["10.1073\/pnas.1820388116"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1820388116","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"2019-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}